Ironwood's Linzess Beats PDUFA Date to Approval in IBS
Ironwood Pharmaceuticals Inc. crossed the commercial threshold Thursday morning, gaining FDA approval of irritable bowel syndrome (IBS) drug linaclotide more than a week ahead of the drug's Sept. 9 PDUFA date.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter